- Home
- FXNC vs SGMO Comparison
FXNC vs SGMO Comparison
Compare FXNC & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FXNC
- SGMO
- Stock Information
- Founded
- FXNC 1907
- SGMO 1995
- Country
- FXNC United States
- SGMO United States
- Employees
- FXNC N/A
- SGMO N/A
- Industry
- FXNC Major Banks
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FXNC Finance
- SGMO Health Care
- Exchange
- FXNC Nasdaq
- SGMO Nasdaq
- Market Cap
- FXNC 203.6M
- SGMO 180.5M
- IPO Year
- FXNC N/A
- SGMO 2000
- Fundamental
- Price
- FXNC $22.62
- SGMO $1.88
- Analyst Decision
- FXNC Strong Buy
- SGMO Buy
- Analyst Count
- FXNC 1
- SGMO 3
- Target Price
- FXNC $21.00
- SGMO $7.00
- AVG Volume (30 Days)
- FXNC 11.8K
- SGMO 9.9M
- Earning Date
- FXNC 11-01-2024
- SGMO 11-12-2024
- Dividend Yield
- FXNC 2.66%
- SGMO N/A
- EPS Growth
- FXNC N/A
- SGMO N/A
- EPS
- FXNC 1.12
- SGMO N/A
- Revenue
- FXNC $48,807,000.00
- SGMO $52,291,000.00
- Revenue This Year
- FXNC N/A
- SGMO N/A
- Revenue Next Year
- FXNC $41.13
- SGMO $71.79
- P/E Ratio
- FXNC $20.11
- SGMO N/A
- Revenue Growth
- FXNC N/A
- SGMO N/A
- 52 Week Low
- FXNC $14.50
- SGMO $0.30
- 52 Week High
- FXNC $24.59
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- FXNC 60.25
- SGMO 49.56
- Support Level
- FXNC $22.45
- SGMO $1.82
- Resistance Level
- FXNC $24.59
- SGMO $2.11
- Average True Range (ATR)
- FXNC 0.58
- SGMO 0.37
- MACD
- FXNC -0.16
- SGMO -0.10
- Stochastic Oscillator
- FXNC 40.12
- SGMO 10.96
About FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. Loan products and services include personal loans, residential mortgages, home equity loans, and commercial loans. Deposit products and services include checking and savings. The Bank's wealth management division offers estate planning, investment management of assets, retirement accounts, and estate settlement.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.